MEHOW INNOVATIVE LTD. Financials Mehow Innovative Ltd.
Equities
301363
CNE100005WP6
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.1 CNY | -2.37% |
|
-2.37% | -31.79% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 17,043 | 14,965 | 10,207 | - | - |
| Enterprise Value (EV) 1 | 17,043 | 14,965 | 10,207 | 10,207 | 10,207 |
| P/E ratio | 38.8 x | 47.8 x | 25.7 x | 20.5 x | 16.4 x |
| Yield | - | 0.43% | 0.86% | 1.08% | 1.57% |
| Capitalization / Revenue | 12 x | 11.2 x | 6.13 x | 4.88 x | 3.9 x |
| EV / Revenue | 12 x | 11.2 x | 6.13 x | 4.88 x | 3.9 x |
| EV / EBITDA | 50.6 x | 34.3 x | 21.8 x | 17.4 x | 13.9 x |
| EV / FCF | - | 153 x | 110 x | 74.5 x | 45.6 x |
| FCF Yield | - | 0.66% | 0.91% | 1.34% | 2.19% |
| Price to Book | 5.64 x | 4.7 x | 2.91 x | 2.6 x | 2.3 x |
| Nbr of stocks (in thousands) | 406,660 | 406,660 | 406,660 | - | - |
| Reference price 2 | 41.91 | 36.80 | 25.10 | 25.10 | 25.10 |
| Announcement Date | 4/17/23 | 4/17/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,415 | 1,338 | 1,666 | 2,090 | 2,614 |
| EBITDA 1 | - | 336.9 | 436 | 467.6 | 587.1 | 734.4 |
| EBIT 1 | - | 456.7 | 351.7 | 447 | 559.6 | 701.1 |
| Operating Margin | - | 32.27% | 26.29% | 26.83% | 26.77% | 26.82% |
| Earnings before Tax (EBT) 1 | - | 456.7 | 351.4 | 446.9 | 559.5 | 701 |
| Net income 1 | 310.1 | 402.1 | 313.3 | 397 | 496.8 | 623.2 |
| Net margin | - | 28.41% | 23.42% | 23.83% | 23.77% | 23.84% |
| EPS 2 | 0.8600 | 1.080 | 0.7700 | 0.9760 | 1.222 | 1.532 |
| Free Cash Flow 1 | - | - | 98.11 | 93 | 137 | 224 |
| FCF margin | - | - | 7.33% | 5.58% | 6.56% | 8.57% |
| FCF Conversion (EBITDA) | - | - | 22.5% | 19.89% | 23.34% | 30.5% |
| FCF Conversion (Net income) | - | - | 31.31% | 23.43% | 27.58% | 35.94% |
| Dividend per Share 2 | - | - | 0.1600 | 0.2150 | 0.2700 | 0.3950 |
| Announcement Date | 9/15/22 | 4/17/23 | 4/17/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 98.1 | 93 | 137 | 224 |
| ROE (net income / shareholders' equity) | - | 21.2% | 10.1% | 11.3% | 12.6% | 14% |
| ROA (Net income/ Total Assets) | - | - | - | 10.2% | 11.3% | 12.3% |
| Assets 1 | - | - | - | 3,892 | 4,396 | 5,088 |
| Book Value Per Share 2 | - | 7.430 | 7.830 | 8.630 | 9.660 | 10.90 |
| Cash Flow per Share 2 | - | 0.9400 | 0.8600 | 0.7800 | 1.010 | 1.240 |
| Capex 1 | - | - | 253 | 402 | 432 | 466 |
| Capex / Sales | - | - | 18.89% | 24.13% | 20.65% | 17.82% |
| Announcement Date | 9/15/22 | 4/17/23 | 4/17/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
25.1
CNY
Average target price
29.42
CNY
Spread / Average Target
+17.23%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.79% | 1.41B | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- 301363 Stock
- Financials Mehow Innovative Ltd.
